Melissa Carr, senior lecturer in leadership development in the Business School, has been nominated
for best paper from a doctoral dissertation at this year’s conference of the Academy of Management. This nomination is as good as winning a lot of other prizes, I assured her. In business and management, the AoM conference is the largest – and nonetheless one of the most difficult to get into. Melissa has had two papers accepted this year.
One of those, “Moments of Discomfort: Poststructuralist Reflexivity and Researcher Subjectivity,” has been put forward for the 2021 William H. Newman Award. Each AoM division nominates one paper. The conference usually attracts more than 10,000 scholars. Participants will hear hundreds and perhaps thousands of papers based on doctoral work, and each division is likely to have dozens from which to pick. They picked hers.
Having read her thesis, which earned her a PhD from Cranfield University, I know it’s a good one. Congratulations!
Donald Nordberg, Associate Professor
Prestigious Prize to be awarded to BU Paralympic Project
Recipient of the VC Fusion Prize 2019 publishes in top Events journal










SPROUT Returns: Designing Sustainability in Research Practice – Wednesday 20 May 12-2pm
Innovative Approaches to Doctoral Supervision: Selected Case Studies
3C Event: Research Culture, Community & Canapés-Tuesday 19 May 1-2pm
New chapters published in maternity book on risk
The British Academy European Research Council Grant Support Sessions
Grant Writing Workshops: Master the Art of the Winning Proposal
Apply now to take part in the 2026 ESRC Festival of Social Science
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease